Literature DB >> 33103835

Structural Insights into the Interaction of Heme with Protein Tyrosine Kinase JAK2*.

Benjamin Franz Schmalohr1, Al-Hassan M Mustafa2, Oliver H Krämer2, Diana Imhof1.   

Abstract

Janus kinase 2 (JAK2) is the most important signal-transducing tyrosine kinase in erythropoietic precursor cells. Its malfunction drives several myeloproliferative disorders. Heme is a small metal-ion-carrying molecule that is incorporated into hemoglobin in erythroid precursor cells to transport oxygen. In addition, heme is a signaling molecule and regulator of various biochemical processes. Here, we show that heme exposure leads to hyperphosphorylation of JAK2 in a myeloid cancer cell line. Two peptides identified in JAK2 are heme-regulatory motifs and show low-micromolar affinities for heme. These peptides map to the kinase domain of JAK2, which is essential for downstream signaling. We suggest these motifs to be the interaction sites of heme with JAK2, which drive the heme-induced hyperphosphorylation. The results presented herein could facilitate the development of heme-related pharmacological tools to combat myeloproliferative disorders.
© 2020 The Authors. Published by Wiley-VCH GmbH.

Entities:  

Keywords:  heme; heme-regulatory motif (HRM); kinases; peptide-protein complexes; phosphorylation

Year:  2020        PMID: 33103835      PMCID: PMC7984354          DOI: 10.1002/cbic.202000730

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  26 in total

Review 1.  JAK2 inhibitors for myeloproliferative neoplasms: what is next?

Authors:  Prithviraj Bose; Srdan Verstovsek
Journal:  Blood       Date:  2017-05-12       Impact factor: 22.113

Review 2.  Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia.

Authors:  Loredana Salerno; Giuseppe Romeo; Maria N Modica; Emanuele Amata; Valeria Sorrenti; Ignazio Barbagallo; Valeria Pittalà
Journal:  Eur J Med Chem       Date:  2017-07-20       Impact factor: 6.514

3.  Jak2 is essential for signaling through a variety of cytokine receptors.

Authors:  E Parganas; D Wang; D Stravopodis; D J Topham; J C Marine; S Teglund; E F Vanin; S Bodner; O R Colamonici; J M van Deursen; G Grosveld; J N Ihle
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

4.  Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1.

Authors:  K Ogawa; J Sun; S Taketani; O Nakajima; C Nishitani; S Sassa; N Hayashi; M Yamamoto; S Shibahara; H Fujita; K Igarashi
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

5.  Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors.

Authors:  A Oda; K Sawada; B J Druker; K Ozaki; H Takano; K Koizumi; Y Fukada; M Handa; T Koike; Y Ikeda
Journal:  Blood       Date:  1998-07-15       Impact factor: 22.113

6.  Analysis of Fe(III) heme binding to cysteine-containing heme-regulatory motifs in proteins.

Authors:  Toni Kühl; Amelie Wißbrock; Nishit Goradia; Nirakar Sahoo; Kerstin Galler; Ute Neugebauer; Jürgen Popp; Stefan H Heinemann; Oliver Ohlenschläger; Diana Imhof
Journal:  ACS Chem Biol       Date:  2013-06-17       Impact factor: 5.100

7.  Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase.

Authors:  Yibing Shan; Kavitha Gnanasambandan; Daniela Ungureanu; Eric T Kim; Henrik Hammarén; Kazuo Yamashita; Olli Silvennoinen; David E Shaw; Stevan R Hubbard
Journal:  Nat Struct Mol Biol       Date:  2014-06-11       Impact factor: 15.369

8.  YASARA View - molecular graphics for all devices - from smartphones to workstations.

Authors:  Elmar Krieger; Gert Vriend
Journal:  Bioinformatics       Date:  2014-07-04       Impact factor: 6.937

9.  CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.

Authors:  Kaosheng Lv; Jing Jiang; Ryan Donaghy; Christopher R Riling; Ying Cheng; Vemika Chandra; Krasimira Rozenova; Wei An; Bhopal C Mohapatra; Benjamin T Goetz; Vinodh Pillai; Xu Han; Emily A Todd; Grace R Jeschke; Wallace Y Langdon; Suresh Kumar; Elizabeth O Hexner; Hamid Band; Wei Tong
Journal:  Genes Dev       Date:  2017-06-13       Impact factor: 11.361

Review 10.  Mechanistic Insights into Regulation of JAK2 Tyrosine Kinase.

Authors:  Stevan R Hubbard
Journal:  Front Endocrinol (Lausanne)       Date:  2018-01-05       Impact factor: 5.555

View more
  2 in total

Review 1.  An Extended C-Terminus, the Possible Culprit for Differential Regulation of 5-Aminolevulinate Synthase Isoforms.

Authors:  Gregory A Hunter; Gloria C Ferreira
Journal:  Front Mol Biosci       Date:  2022-07-14

2.  Structural Insights into the Interaction of Heme with Protein Tyrosine Kinase JAK2*.

Authors:  Benjamin Franz Schmalohr; Al-Hassan M Mustafa; Oliver H Krämer; Diana Imhof
Journal:  Chembiochem       Date:  2020-11-19       Impact factor: 3.164

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.